These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 9777184

  • 1. Enhancement of antipsychoticlike properties of raclopride in rats using the selective serotonin2A receptor antagonist MDL 100,907.
    Wadenberg ML, Hicks PB, Richter JT, Young KA.
    Biol Psychiatry; 1998 Sep 15; 44(6):508-15. PubMed ID: 9777184
    [Abstract] [Full Text] [Related]

  • 2. Antagonism at 5-HT(2A) receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats.
    Wadenberg MG, Browning JL, Young KA, Hicks PB.
    Pharmacol Biochem Behav; 2001 Mar 15; 68(3):363-70. PubMed ID: 11325387
    [Abstract] [Full Text] [Related]

  • 3. M100907 and clozapine, but not haloperidol or raclopride, prevent phencyclidine-induced blockade of NMDA responses in pyramidal neurons of the rat medial prefrontal cortical slice.
    Wang RY, Liang X.
    Neuropsychopharmacology; 1998 Jul 15; 19(1):74-85. PubMed ID: 9608579
    [Abstract] [Full Text] [Related]

  • 4. Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile.
    Kehne JH, Baron BM, Carr AA, Chaney SF, Elands J, Feldman DJ, Frank RA, van Giersbergen PL, McCloskey TC, Johnson MP, McCarty DR, Poirot M, Senyah Y, Siegel BW, Widmaier C.
    J Pharmacol Exp Ther; 1996 May 15; 277(2):968-81. PubMed ID: 8627580
    [Abstract] [Full Text] [Related]

  • 5. Enhancement of antipsychotic-like properties of the dopamine D2 receptor antagonist, raclopride, by the additional treatment with the 5-HT2 receptor blocking agent, ritanserin, in the rat.
    Wadenberg ML, Salmi P, Jimenez P, Svensson T, Ahlenius S.
    Eur Neuropsychopharmacol; 1996 Nov 15; 6(4):305-10. PubMed ID: 8985714
    [Abstract] [Full Text] [Related]

  • 6. Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone.
    Martin P, Waters N, Schmidt CJ, Carlsson A, Carlsson ML.
    J Neural Transm (Vienna); 1998 Nov 15; 105(4-5):365-96. PubMed ID: 9720968
    [Abstract] [Full Text] [Related]

  • 7. Does antagonism at 5-HT2A receptors potentiate D₂ blockade-induced disruption of conditioned avoidance response?
    Gao J, Huang Y, Li M.
    Exp Clin Psychopharmacol; 2019 Apr 15; 27(2):103-108. PubMed ID: 30556732
    [Abstract] [Full Text] [Related]

  • 8. 5-HT modulation of auditory and visual sensorimotor gating: II. Effects of the 5-HT2A antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats.
    Padich RA, McCloskey TC, Kehne JH.
    Psychopharmacology (Berl); 1996 Mar 15; 124(1-2):107-16. PubMed ID: 8935805
    [Abstract] [Full Text] [Related]

  • 9. Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system.
    Andersson JL, Nomikos GG, Marcus M, Hertel P, Mathé JM, Svensson TH.
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Oct 15; 352(4):374-85. PubMed ID: 8532065
    [Abstract] [Full Text] [Related]

  • 10. A novel computer-controlled conditioned avoidance apparatus for rats.
    Wadenberg ML, Young KA, Trompler RA, Zavodny RA, Richter TJ, Hicks PB.
    J Pharmacol Toxicol Methods; 1997 Dec 15; 38(4):211-5. PubMed ID: 9566445
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the effects of α2 adrenoceptor antagonism with the D2 receptor antagonist raclopride on conditioned avoidance responding in rats.
    Jacobson SM, Prus AJ.
    Behav Pharmacol; 2010 Oct 15; 21(7):654-9. PubMed ID: 20729715
    [Abstract] [Full Text] [Related]

  • 12. MK-801-induced hyperlocomotion: differential effects of M100907, SDZ PSD 958 and raclopride.
    Martin P, Waters N, Waters S, Carlsson A, Carlsson ML.
    Eur J Pharmacol; 1997 Sep 24; 335(2-3):107-16. PubMed ID: 9369362
    [Abstract] [Full Text] [Related]

  • 13. Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effects without catalepsy.
    Wadenberg ML, Ahlenius S.
    J Neural Transm Gen Sect; 1991 Sep 24; 83(1-2):43-53. PubMed ID: 1673344
    [Abstract] [Full Text] [Related]

  • 14. M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats.
    Varty GB, Bakshi VP, Geyer MA.
    Neuropsychopharmacology; 1999 Apr 24; 20(4):311-21. PubMed ID: 10088132
    [Abstract] [Full Text] [Related]

  • 15. Enhancement of antipsychotic-like effects by combined treatment with the alpha1-adrenoceptor antagonist prazosin and the dopamine D2 receptor antagonist raclopride in rats.
    Wadenberg ML, Hertel P, Fernholm R, Hygge Blakeman K, Ahlenius S, Svensson TH.
    J Neural Transm (Vienna); 2000 Apr 24; 107(10):1229-38. PubMed ID: 11129112
    [Abstract] [Full Text] [Related]

  • 16. Adjunctive galantamine, but not donepezil, enhances the antipsychotic-like effect of raclopride in rats.
    Wiker C, Schilström B, Sandbäck C, Wadenberg ML, Svensson TH.
    Int J Neuropsychopharmacol; 2008 Sep 24; 11(6):845-50. PubMed ID: 18405415
    [Abstract] [Full Text] [Related]

  • 17. Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens.
    Ichikawa J, Kuroki T, Dai J, Meltzer HY.
    Eur J Pharmacol; 1998 Jun 19; 351(2):163-71. PubMed ID: 9686999
    [Abstract] [Full Text] [Related]

  • 18. Blockade of phencyclidine-induced hyperlocomotion by clozapine and MDL 100,907 in rats reflects antagonism of 5-HT2A receptors.
    Maurel-Remy S, Bervoets K, Millan MJ.
    Eur J Pharmacol; 1995 Jul 04; 280(2):R9-11. PubMed ID: 7589172
    [Abstract] [Full Text] [Related]

  • 19. M100907, a selective 5-HT2A receptor antagonist and a potential antipsychotic drug, facilitates N-methyl-D-aspartate-receptor mediated neurotransmission in the rat medial prefrontal cortical neurons in vitro.
    Arvanov VL, Wang RY.
    Neuropsychopharmacology; 1998 Mar 04; 18(3):197-209. PubMed ID: 9471117
    [Abstract] [Full Text] [Related]

  • 20. Risperidone inhibits 5-hydroxytryptaminergic neuronal activity in the dorsal raphe nucleus by local release of 5-hydroxytryptamine.
    Hertel P, Nomikos GG, Svensson TH.
    Br J Pharmacol; 1997 Dec 04; 122(8):1639-46. PubMed ID: 9422809
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.